Takeda

Takeda Eyes Plasma Therapy for Covid-19 Patients

Via The Street “Japanese drug maker Takeda is planning to use an old therapy technology for a new disease, Covid-19. The company is developing a plasma-derived therapy, dubbed TAK-888, that would be similar to plasma-based treatments previously used on other severe acute viral infections, including during the Ebola crisis, that is based on technology believed to […]

In the Know: Healthcare News for March 9, 2020

COVID-19: How Mayo Clinic is preparing to respond to a potential pandemic Vice President Mike Pence visits 3M on coronavirus tour Takeda Pharma says it is developing coronavirus drug Coronavirus – How Health Plans Can Help Their Members Stay Safe from COVID-19 Right Now CE Mark for Abbott’s FlexNav Delivery System for TAVI Valve Sanofi […]

In The Know: Healthcare News for March 2, 2020

PhysIQ and U.S. Veteran’s Affairs Publish Breakthrough Study Takeda Takes Aim at Becoming World Leader in Treating Celiac and Other GI Disorders Abilitech aims to arm people with independence Medtronic names its first chief inclusion and diversity officer Cleveland Clinic spinout Cardionomic raises $16 million Abbott touts real-world data around FreeStyle Libre system gBETA Medtech […]

In the Know: Healthcare News for February 17, 2010

Carrot Health Named Top Innovator in Accenture HealthTech Innovation Challenge Nference Poised for Growth Following Mayo Clinic Investment, Partnership Minnesota Partnership Awards Leverage Top Experts Against Disease Medtronic to bolster its AI, surgical robotics work with Digital Surgery acquisition Takeda Pharmaceuticals invests in data management platform Seqster Medtronic and the Medtronic Foundation Commit More Than […]

In the Know: Healthcare News for November 11, 2019

Stryker announces definitive agreement to acquire Wright Medical for $5.4 Billion Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for Cancer Maple Grove-based Pursuit Vascular sold for $75 million to California firm Digi International spends $140 million to buy New Jersey IT company In $660 Million Deal, Takeda […]

In the Know — Healthcare News for May 27, 2019

Apple Watch app for nightmare disorder receives FDA breakthrough designation, opens enrollment for two RCTs MagStim wins FDA nod, launches StimGuide TMS navigation system Buoyed by CGT growth, Bio-Techne plans plant to supply $200m of reagents Minneapolis med-tech firm SynerFuse raises $2.6M FDA Approves Extension of Treatment for Short Bowel Syndrome to Include Children Strategic […]

In the Know: Healthcare News for May 20, 2019

Abbott Partners With NIH On BRAIN Initiative to Advance Research for Neurological Disorders Generic drugmaker Upsher-Smith plans Maple Grove expansion CVRx data show its device can benefit heart-failure patients 76% of Patients Positively Impacted Within 12 weeks in new MIRODERM Clinical Study Bright Health to expand into 5 new states next year VentureMed Group Grows […]

In The Know — Healthcare News for May 3, 2019

3M buying Acelity in deal worth $6.7B Medtronic wins FDA approval for CareLink SmartSync CRM device manager Biotech firm Miromatrix Receives KidneyX Redesign Dialysis Phase I award NIH taps StemoniX’s organ-on-a-chip for opioid, addiction research Report: Takeda adopts value-based pricing for Crohn’s stem cell therapy in Europe Med-tech firm NeoChord adds $7M to earlier $25M […]

In the Know — March 18, 2019

Forging a new path for health care Immigration to US Westernizes Asian guts Lancaster-based Smart Health Innovation Lab’s 3rd client, OneOme, has Mayo Clinic ties FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation Boston Scientific wins CE Mark for Watchman FLX anti-stroke implant POPS! Diabetes Care […]

UMN’s BioTechnology Institute and Takeda Pharmaceutical Announce Training Partnership Focused on Biopharma

The University of Minnesota’s BioTechnology Institute (BTI), in conjunction with the College of Biological Sciences (CBS), and Tokyo-based Takeda Pharmaceutical Co., through its subsidiary Millennium Pharmaceuticals, have entered into an advanced workforce training partnership. They recently received a grant awarded by the State of Minnesota Job Skills Partnership (MJSP) Board to kick start their training efforts.  Over the next […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER